Clinical Trials

A Phase II/III Study to Evaluate the Efficacy and Safety of Unesbulin in Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma (SUNRISE LMS)

Link :
Population : LMS (fever than 4 lines of prior treatment)
Description : DTIC + unesbulin/placebo
PI : A. Gupta
Centers Opened : Princess Margaret Cancer Centre
Phase : II/III
IIST/Pharma : Pharma